Literature DB >> 20042854

Expression of thyroid transcription factor-1 in colorectal carcinoma.

Bo Xu1, Nguyen Thong, Dongfeng Tan, Thaer Khoury.   

Abstract

Thyroid transcription factor-1 (TTF-1) is a member of the homeodomain transcription family expressed in epithelial cells of the thyroid and lung. Although nuclear TTF-1 is generally considered a specific marker for lung and thyroid neoplasms, it has been reported to be positive in other types of tumors including colorectal carcinoma (CRC). During metastatic adenocarcinoma workup for patients who had a history of CRC, we identified 4 positive TTF-1 cases using clone 8G7G3/1. Three of the 4 corresponding primary carcinomas were also positive for TTF-1. Therefore, we sought to retrospectively investigate the expression of TTF-1 in 100 CRC cases constructed in tissue microarray blocks and whole tissue sections of the 4 primary tumors corresponding to the 4 positive metastases. In tissue microarray cases, all cases had negative nuclear staining. Our results suggest that during immunohistochemical workup for adenocarcinoma, especially when the differential diagnosis includes the lung and CRC, TTF-1 results should be interpreted with caution as a small percentage of CRC expresses this marker. Positive nuclear TTF-1 in a metastatic carcinoma does not rule out CRC primary. Clinicopathologic correlation, tumor morphology, and a panel of immunohistochemical markers are essential to render the correct diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20042854     DOI: 10.1097/PAI.0b013e3181c29407

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

1.  Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.

Authors:  J Cheng; R P Ondracek; D C Mehedint; K A Kasza; B Xu; S Gill; G Azabdaftari; S Yao; C D Morrison; J L Mohler; J R Marshall
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-04-14       Impact factor: 5.554

2.  Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.

Authors:  Ying-Wei Li; He Shen; Costa Frangou; Nuo Yang; Jin Guo; Bo Xu; Wiam Bshara; Lori Shepherd; Qianqian Zhu; Jianmin Wang; Qiang Hu; Song Liu; Carl D Morrison; Peiqing Sun; Jianmin Zhang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.

Authors:  Dongbo Xu; Qiang Cao; Li Wang; Jianmin Wang; Bo Xu; Kristopher Attwood; Lei Wei; Yue Wu; Gary J Smith; Eriko Katsuta; Kazuaki Takabe; Gurkamal Chatta; Khurshid A Guru; David W Goodrich; Qiang J Li
Journal:  Mol Cancer Ther       Date:  2022-05-04       Impact factor: 6.009

4.  Ancillary testing in lung cancer diagnosis.

Authors:  William Dubinski; Natasha B Leighl; Ming-Sound Tsao; David M Hwang
Journal:  Pulm Med       Date:  2012-01-04

5.  Primary signet ring cell carcinoma of the lung with cerebellar metastasis showing full response to Cisplatin and docetaxel therapy.

Authors:  Onur Kocas; Fatih Selcukbiricik; Ahmet Bilici; Metin Kanıtez; Serdar Yildiz; Suna Avci; Canan Tanik
Journal:  Case Rep Oncol Med       Date:  2014-01-09

6.  TTF-1 Expression in Rectal Adenocarcinoma: A Case Report and Review of the Literature.

Authors:  Astrid Belalcazar; Uma Krishnamurti; Walid Shaib
Journal:  Case Rep Oncol       Date:  2016-11-18

Review 7.  Pathologic differential diagnosis of metastatic carcinoma in the liver.

Authors:  Jeong Hwan Park; Jung Ho Kim
Journal:  Clin Mol Hepatol       Date:  2018-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.